BIOMAT Database Logo BIOMAT Database Logo

Effect of sperm treatment with exogenous platelet-activating factor on the outcome of intrauterine insemination. 2005

Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Assisted Reproduction Unit, 2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece.

OBJECTIVE To evaluate the effect of sperm treatment with exogenous platelet-activating factor (PAF) on IUI clinical pregnancy rate. METHODS Prospective randomized study. METHODS Assisted Reproduction Unit, 2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece. METHODS Fifty-two couples with unexplained infertility, candidates for IUI. METHODS Sperm treatment with an exogenous mixture of PAF (final concentration, 10(-7) mol/L) in sperm-washing medium, direct swim-up technique of sperm preparation, a maximum of six IUI cycles per couple with or without PAF treatment. METHODS Clinical pregnancy rate (pregnancies confirmed by ultrasonography per hundred cycles). RESULTS The overall clinical pregnancy rate after a maximum of six IUI cycles was significantly higher when sperm was treated with PAF compared with the rate after the direct swim-up technique (23.07% vs. 7.92%). CONCLUSIONS Treatment of sperm with exogenous PAF might improve the clinical outcome of IUI in cases of unexplained infertility.

UI MeSH Term Description Entries
D007246 Infertility A reduced or absent capacity to reproduce. Sterility,Reproductive Sterility,Sterility, Reproductive,Sub-Fertility,Subfertility
D007317 Insemination, Artificial, Homologous Human artificial insemination in which the husband's semen is used. Insemination, Artificial, Husband,AIH,Artificial Insemination, Husband,Homologous Insemination,Insemination, Homologous,Husband Artificial Insemination,Insemination, Husband Artificial
D008297 Male Males
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013094 Spermatozoa Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility. Sperm,Spermatozoon,X-Bearing Sperm,X-Chromosome-Bearing Sperm,Y-Bearing Sperm,Y-Chromosome-Bearing Sperm,Sperm, X-Bearing,Sperm, X-Chromosome-Bearing,Sperm, Y-Bearing,Sperm, Y-Chromosome-Bearing,Sperms, X-Bearing,Sperms, X-Chromosome-Bearing,Sperms, Y-Bearing,Sperms, Y-Chromosome-Bearing,X Bearing Sperm,X Chromosome Bearing Sperm,X-Bearing Sperms,X-Chromosome-Bearing Sperms,Y Bearing Sperm,Y Chromosome Bearing Sperm,Y-Bearing Sperms,Y-Chromosome-Bearing Sperms

Related Publications

Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Platelet-activating factor improves intrauterine insemination outcome.
May 2001, American journal of obstetrics and gynecology,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Platelet activating factor does not improve intrauterine insemination outcome.
November 2001, American journal of obstetrics and gynecology,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Effect of sperm chromatin condensation on the outcome of intrauterine insemination in patients with male factor infertility.
January 2012, The Journal of reproductive medicine,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Effect of postprepared sperm parameters and insemination specimen volume on the outcome of intrauterine insemination.
September 1998, Changgeng yi xue za zhi,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
[Effect of platelet-activating factor on sperm function].
June 2007, Zhonghua nan ke xue = National journal of andrology,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Effect of insemination timing on pregnancy outcome in association with female age, sperm motility, sperm morphology and sperm concentration in intrauterine insemination.
June 2018, The journal of obstetrics and gynaecology research,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
The Effect of Sperm DNA Fragmentation Index on the Outcome of Intrauterine Insemination and Intracytoplasmic Sperm Injection.
January 2019, Journal of human reproductive sciences,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Effect of motile sperm count after swim-up on outcome of intrauterine insemination.
April 1997, Fertility and sterility,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated.
March 2002, American journal of obstetrics and gynecology,
Odysseas Grigoriou, and Evangelos Makrakis, and Socrates Konidaris, and Dimitrios Hassiakos, and Konstantinos Papadias, and Stavroula Baka, and George Creatsas
Effect of age on intrauterine insemination with frozen donor sperm.
July 1996, Obstetrics and gynecology,
Copied contents to your clipboard!